Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in California

To assess the clinical impact of a molecular beacon (MB) assay that detects multidrug-resistant tuberculosis (MDR TB), we retrospectively reviewed records of 127 MDR TB patients with and without MB testing between 2004 and 2007. Use of the MB assay reduced the time to detection and treatment of MDR...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of clinical microbiology Ročník 48; číslo 10; s. 3779
Hlavní autori:	Banerjee, Ritu, Allen, Jennifer, Lin, S-Y Grace, Westenhouse, Janice, Desmond, Ed, Schecter, Gisela F, Scott, Cheryl, Raftery, Ann, Mase, Sundari, Watt, James P, Flood, Jennifer
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.10.2010
Predmet:	Adult Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use California Early Diagnosis Female Humans Male Microbial Sensitivity Tests - methods Middle Aged Molecular Diagnostic Techniques - methods Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - genetics Mycobacterium tuberculosis - isolation & purification Retrospective Studies Time Factors Tuberculosis, Multidrug-Resistant - diagnosis Tuberculosis, Multidrug-Resistant - microbiology California
ISSN:	1098-660X, 1098-660X
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!